| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tanzania | 289 | 2023 | 1346 | 18.690 |
Why?
|
| Dietary Supplements | 140 | 2024 | 3296 | 11.740 |
Why?
|
| HIV Infections | 249 | 2023 | 16715 | 11.340 |
Why?
|
| Vitamin A | 66 | 2022 | 615 | 10.480 |
Why?
|
| Vitamins | 79 | 2023 | 1623 | 10.390 |
Why?
|
| Anemia | 42 | 2023 | 1503 | 9.950 |
Why?
|
| Pregnancy Complications, Infectious | 96 | 2022 | 2026 | 9.780 |
Why?
|
| Anemia, Iron-Deficiency | 26 | 2023 | 365 | 8.460 |
Why?
|
| Micronutrients | 40 | 2023 | 375 | 7.860 |
Why?
|
| Nutritional Status | 76 | 2024 | 1609 | 7.550 |
Why?
|
| Infectious Disease Transmission, Vertical | 70 | 2019 | 1320 | 6.520 |
Why?
|
| Malnutrition | 31 | 2024 | 625 | 6.210 |
Why?
|
| Antiretroviral Therapy, Highly Active | 30 | 2020 | 1872 | 5.770 |
Why?
|
| Growth Disorders | 39 | 2022 | 645 | 5.730 |
Why?
|
| Premature Birth | 41 | 2024 | 1721 | 5.600 |
Why?
|
| Vitamin A Deficiency | 23 | 2021 | 101 | 5.170 |
Why?
|
| Pregnancy Outcome | 51 | 2023 | 2795 | 4.750 |
Why?
|
| Diet | 58 | 2023 | 7937 | 4.730 |
Why?
|
| Tuberculosis, Pulmonary | 23 | 2022 | 810 | 4.700 |
Why?
|
| Pregnancy | 233 | 2024 | 29144 | 4.250 |
Why?
|
| Zinc | 24 | 2023 | 684 | 4.210 |
Why?
|
| Infant Mortality | 33 | 2022 | 754 | 4.140 |
Why?
|
| Iron | 25 | 2023 | 1774 | 4.130 |
Why?
|
| Child Development | 41 | 2024 | 2223 | 4.010 |
Why?
|
| Developing Countries | 43 | 2024 | 2815 | 3.910 |
Why?
|
| CD4 Lymphocyte Count | 55 | 2019 | 2560 | 3.840 |
Why?
|
| Anti-HIV Agents | 44 | 2020 | 4255 | 3.710 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 21 | 2021 | 378 | 3.680 |
Why?
|
| Hemoglobins | 30 | 2023 | 1532 | 3.350 |
Why?
|
| Infant, Low Birth Weight | 24 | 2022 | 850 | 3.340 |
Why?
|
| Milk, Human | 16 | 2023 | 490 | 3.330 |
Why?
|
| Infant Nutritional Physiological Phenomena | 19 | 2019 | 347 | 3.280 |
Why?
|
| Vitamin D Deficiency | 15 | 2022 | 1343 | 3.270 |
Why?
|
| Ethiopia | 23 | 2023 | 495 | 3.260 |
Why?
|
| HIV-1 | 68 | 2017 | 6939 | 3.240 |
Why?
|
| Folic Acid | 16 | 2023 | 1300 | 3.230 |
Why?
|
| Iron, Dietary | 11 | 2023 | 141 | 3.190 |
Why?
|
| Breast Feeding | 43 | 2020 | 1338 | 3.180 |
Why?
|
| Rural Population | 33 | 2022 | 2207 | 3.100 |
Why?
|
| Anthropometry | 23 | 2021 | 1350 | 3.080 |
Why?
|
| Infant, Small for Gestational Age | 23 | 2022 | 440 | 2.990 |
Why?
|
| Infant, Newborn | 154 | 2024 | 25628 | 2.970 |
Why?
|
| Vitamin B 12 | 10 | 2023 | 527 | 2.930 |
Why?
|
| Pregnancy Complications | 19 | 2023 | 2861 | 2.870 |
Why?
|
| Infant | 181 | 2023 | 35134 | 2.760 |
Why?
|
| Child Nutritional Physiological Phenomena | 15 | 2021 | 303 | 2.740 |
Why?
|
| Vitamin D | 24 | 2022 | 3224 | 2.720 |
Why?
|
| Food Supply | 8 | 2021 | 524 | 2.680 |
Why?
|
| Prenatal Care | 22 | 2023 | 1092 | 2.620 |
Why?
|
| Female | 459 | 2024 | 380193 | 2.560 |
Why?
|
| Lactation | 10 | 2022 | 412 | 2.370 |
Why?
|
| Selenium | 12 | 2014 | 405 | 2.370 |
Why?
|
| Schools | 14 | 2023 | 1433 | 2.370 |
Why?
|
| Adult | 289 | 2023 | 214052 | 2.310 |
Why?
|
| Agriculture | 5 | 2023 | 186 | 2.310 |
Why?
|
| Birth Weight | 29 | 2022 | 2069 | 2.300 |
Why?
|
| Respiratory Tract Infections | 11 | 2021 | 961 | 2.280 |
Why?
|
| Growth | 12 | 2019 | 376 | 2.270 |
Why?
|
| Tuberculosis | 14 | 2020 | 1912 | 2.230 |
Why?
|
| AIDS-Related Opportunistic Infections | 9 | 2017 | 657 | 2.190 |
Why?
|
| Young Adult | 140 | 2023 | 56429 | 2.180 |
Why?
|
| Humans | 554 | 2024 | 744366 | 2.180 |
Why?
|
| HIV Wasting Syndrome | 8 | 2014 | 97 | 2.160 |
Why?
|
| Double-Blind Method | 75 | 2023 | 12025 | 2.140 |
Why?
|
| Diarrhea | 20 | 2020 | 1348 | 2.140 |
Why?
|
| Anti-Retroviral Agents | 17 | 2021 | 1714 | 2.050 |
Why?
|
| Thinness | 19 | 2022 | 480 | 2.040 |
Why?
|
| Cross-Sectional Studies | 89 | 2023 | 25039 | 1.980 |
Why?
|
| Child Mortality | 10 | 2017 | 198 | 1.920 |
Why?
|
| Fetal Growth Retardation | 9 | 2022 | 570 | 1.860 |
Why?
|
| Vitamin B Complex | 10 | 2014 | 288 | 1.820 |
Why?
|
| Cholecalciferol | 7 | 2022 | 535 | 1.810 |
Why?
|
| Malaria | 14 | 2020 | 1239 | 1.800 |
Why?
|
| Adolescent | 126 | 2024 | 85779 | 1.790 |
Why?
|
| Overweight | 16 | 2023 | 2371 | 1.760 |
Why?
|
| Socioeconomic Factors | 53 | 2023 | 7785 | 1.680 |
Why?
|
| Child, Preschool | 111 | 2024 | 41005 | 1.660 |
Why?
|
| Fatty Acids, Omega-6 | 4 | 2019 | 227 | 1.640 |
Why?
|
| Child Nutrition Disorders | 6 | 2022 | 149 | 1.640 |
Why?
|
| Vitamin E | 11 | 2014 | 869 | 1.620 |
Why?
|
| Nutritive Value | 5 | 2021 | 339 | 1.620 |
Why?
|
| Africa South of the Sahara | 22 | 2021 | 724 | 1.580 |
Why?
|
| Male | 264 | 2023 | 350115 | 1.570 |
Why?
|
| HIV Seropositivity | 14 | 2012 | 971 | 1.560 |
Why?
|
| Prospective Studies | 104 | 2023 | 53290 | 1.520 |
Why?
|
| Gestational Age | 21 | 2022 | 3493 | 1.500 |
Why?
|
| Trace Elements | 7 | 2017 | 198 | 1.500 |
Why?
|
| Mental Health | 9 | 2022 | 3010 | 1.490 |
Why?
|
| Burkina Faso | 10 | 2023 | 88 | 1.490 |
Why?
|
| Prevalence | 68 | 2022 | 15221 | 1.480 |
Why?
|
| Body Height | 26 | 2019 | 1578 | 1.450 |
Why?
|
| Gardening | 2 | 2020 | 19 | 1.450 |
Why?
|
| Viral Load | 26 | 2021 | 3300 | 1.420 |
Why?
|
| Weight Gain | 18 | 2023 | 2293 | 1.410 |
Why?
|
| Risk Factors | 133 | 2023 | 72296 | 1.400 |
Why?
|
| Morbidity | 20 | 2023 | 1768 | 1.380 |
Why?
|
| Child | 99 | 2023 | 77709 | 1.360 |
Why?
|
| Dietary Proteins | 7 | 2023 | 963 | 1.340 |
Why?
|
| Ascorbic Acid | 7 | 2014 | 651 | 1.320 |
Why?
|
| Chickens | 2 | 2021 | 865 | 1.320 |
Why?
|
| Wasting Syndrome | 11 | 2021 | 101 | 1.320 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 6 | 2023 | 159 | 1.300 |
Why?
|
| Motor Skills | 6 | 2019 | 522 | 1.290 |
Why?
|
| Urban Population | 13 | 2021 | 2022 | 1.280 |
Why?
|
| Educational Status | 18 | 2022 | 2540 | 1.280 |
Why?
|
| Food, Fortified | 6 | 2019 | 191 | 1.270 |
Why?
|
| Flour | 2 | 2018 | 19 | 1.260 |
Why?
|
| Stillbirth | 7 | 2023 | 346 | 1.250 |
Why?
|
| Placenta | 8 | 2022 | 1699 | 1.250 |
Why?
|
| India | 19 | 2022 | 2197 | 1.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 10 | 2021 | 3922 | 1.230 |
Why?
|
| Infant Nutrition Disorders | 4 | 2018 | 73 | 1.160 |
Why?
|
| Randomized Controlled Trials as Topic | 36 | 2024 | 9955 | 1.150 |
Why?
|
| Poverty | 10 | 2021 | 2660 | 1.150 |
Why?
|
| Parasitemia | 7 | 2012 | 173 | 1.130 |
Why?
|
| Pregnancy Complications, Parasitic | 6 | 2017 | 54 | 1.120 |
Why?
|
| Income | 6 | 2021 | 1913 | 1.110 |
Why?
|
| Ferritins | 10 | 2023 | 590 | 1.110 |
Why?
|
| Health Status | 11 | 2021 | 4034 | 1.090 |
Why?
|
| Mothers | 18 | 2022 | 2165 | 1.070 |
Why?
|
| Cohort Studies | 62 | 2022 | 40559 | 1.060 |
Why?
|
| Pneumonia | 9 | 2013 | 2133 | 1.020 |
Why?
|
| Malaria, Falciparum | 7 | 2017 | 1077 | 1.000 |
Why?
|
| Proportional Hazards Models | 33 | 2019 | 12356 | 1.000 |
Why?
|
| Body Mass Index | 35 | 2023 | 12721 | 0.980 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 3 | 2022 | 912 | 0.970 |
Why?
|
| Sexual Behavior | 4 | 2019 | 2055 | 0.960 |
Why?
|
| Nutrition Policy | 6 | 2021 | 488 | 0.960 |
Why?
|
| Body Weight | 27 | 2017 | 4671 | 0.960 |
Why?
|
| Arm | 5 | 2021 | 589 | 0.940 |
Why?
|
| Acquired Immunodeficiency Syndrome | 10 | 2023 | 2232 | 0.940 |
Why?
|
| Animal Husbandry | 2 | 2021 | 66 | 0.940 |
Why?
|
| Sex Factors | 27 | 2022 | 10400 | 0.880 |
Why?
|
| Pregnancy Complications, Hematologic | 4 | 2019 | 183 | 0.880 |
Why?
|
| Social Stigma | 3 | 2021 | 701 | 0.870 |
Why?
|
| Uganda | 12 | 2021 | 1237 | 0.870 |
Why?
|
| Pregnant Women | 5 | 2023 | 568 | 0.870 |
Why?
|
| Deficiency Diseases | 3 | 2018 | 72 | 0.870 |
Why?
|
| Postpartum Period | 5 | 2020 | 1086 | 0.860 |
Why?
|
| HIV | 4 | 2020 | 1604 | 0.860 |
Why?
|
| Nutrition Disorders | 7 | 2003 | 211 | 0.850 |
Why?
|
| Virus Shedding | 5 | 2010 | 108 | 0.840 |
Why?
|
| Adolescent Development | 3 | 2021 | 279 | 0.830 |
Why?
|
| Disease Progression | 31 | 2022 | 13286 | 0.820 |
Why?
|
| Social Class | 10 | 2017 | 1997 | 0.820 |
Why?
|
| Antitubercular Agents | 11 | 2020 | 1320 | 0.820 |
Why?
|
| Calcium | 7 | 2024 | 5755 | 0.810 |
Why?
|
| Prenatal Exposure Delayed Effects | 11 | 2019 | 2408 | 0.810 |
Why?
|
| Research Design | 15 | 2024 | 5984 | 0.800 |
Why?
|
| Communicable Diseases | 4 | 2022 | 880 | 0.800 |
Why?
|
| Health Behavior | 7 | 2020 | 2635 | 0.790 |
Why?
|
| Demography | 5 | 2021 | 1655 | 0.780 |
Why?
|
| RNA, Viral | 7 | 2014 | 2901 | 0.780 |
Why?
|
| Middle Aged | 95 | 2023 | 213390 | 0.780 |
Why?
|
| Community-Based Participatory Research | 2 | 2019 | 214 | 0.770 |
Why?
|
| Crops, Agricultural | 1 | 2021 | 36 | 0.770 |
Why?
|
| Cognition | 14 | 2022 | 6770 | 0.770 |
Why?
|
| Incidence | 36 | 2020 | 20952 | 0.770 |
Why?
|
| Patient Compliance | 5 | 2020 | 2684 | 0.750 |
Why?
|
| Nigeria | 6 | 2022 | 733 | 0.740 |
Why?
|
| Fetal Development | 5 | 2021 | 767 | 0.740 |
Why?
|
| Folic Acid Deficiency | 2 | 2019 | 115 | 0.730 |
Why?
|
| Aflatoxin B1 | 1 | 2019 | 18 | 0.730 |
Why?
|
| Developmental Disabilities | 6 | 2024 | 1456 | 0.720 |
Why?
|
| Adolescent Behavior | 3 | 2021 | 1151 | 0.710 |
Why?
|
| Sudan | 17 | 2016 | 83 | 0.710 |
Why?
|
| Placebos | 15 | 2020 | 1676 | 0.710 |
Why?
|
| Opportunistic Infections | 2 | 2013 | 389 | 0.700 |
Why?
|
| Obesity | 16 | 2023 | 12746 | 0.690 |
Why?
|
| Hypercalcemia | 1 | 2022 | 409 | 0.690 |
Why?
|
| Energy Intake | 8 | 2022 | 2148 | 0.690 |
Why?
|
| Eggs | 1 | 2020 | 184 | 0.680 |
Why?
|
| Multivariate Analysis | 25 | 2018 | 12244 | 0.680 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2022 | 489 | 0.670 |
Why?
|
| Nevirapine | 6 | 2019 | 267 | 0.670 |
Why?
|
| HIV Seronegativity | 4 | 2022 | 211 | 0.670 |
Why?
|
| Pregnancy Trimester, Second | 9 | 2021 | 732 | 0.670 |
Why?
|
| Pregnancy Trimester, Third | 7 | 2022 | 571 | 0.660 |
Why?
|
| Age Factors | 29 | 2021 | 18373 | 0.660 |
Why?
|
| Hematologic Tests | 1 | 2020 | 240 | 0.660 |
Why?
|
| Vitamin B 12 Deficiency | 4 | 2019 | 116 | 0.650 |
Why?
|
| Conservation of Natural Resources | 3 | 2017 | 204 | 0.650 |
Why?
|
| Infant, Premature | 10 | 2018 | 2045 | 0.650 |
Why?
|
| Health Priorities | 1 | 2021 | 380 | 0.650 |
Why?
|
| Oils | 1 | 2018 | 63 | 0.640 |
Why?
|
| Triticum | 1 | 2018 | 86 | 0.640 |
Why?
|
| Urban Health | 6 | 2015 | 547 | 0.630 |
Why?
|
| Longitudinal Studies | 24 | 2021 | 13991 | 0.630 |
Why?
|
| Treatment Failure | 6 | 2018 | 2618 | 0.620 |
Why?
|
| Maternal Welfare | 4 | 2012 | 115 | 0.620 |
Why?
|
| Follow-Up Studies | 41 | 2021 | 39052 | 0.620 |
Why?
|
| Treatment Outcome | 46 | 2022 | 63107 | 0.620 |
Why?
|
| Linear Models | 16 | 2021 | 5953 | 0.620 |
Why?
|
| Pre-Eclampsia | 3 | 2024 | 1200 | 0.610 |
Why?
|
| Lamivudine | 2 | 2016 | 342 | 0.610 |
Why?
|
| World Health Organization | 5 | 2016 | 1318 | 0.610 |
Why?
|
| Microcephaly | 1 | 2022 | 432 | 0.610 |
Why?
|
| Nutritional Support | 3 | 2016 | 168 | 0.600 |
Why?
|
| Nutrition Surveys | 6 | 2021 | 1660 | 0.600 |
Why?
|
| Arginine | 2 | 2019 | 944 | 0.600 |
Why?
|
| Capacity Building | 1 | 2019 | 248 | 0.590 |
Why?
|
| Weight Loss | 6 | 2022 | 2625 | 0.570 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 352 | 0.570 |
Why?
|
| Minerals | 3 | 2017 | 275 | 0.570 |
Why?
|
| Angiogenic Proteins | 1 | 2016 | 104 | 0.560 |
Why?
|
| beta Carotene | 6 | 2010 | 527 | 0.550 |
Why?
|
| Infant Welfare | 3 | 2012 | 81 | 0.550 |
Why?
|
| Diet Surveys | 7 | 2021 | 1173 | 0.550 |
Why?
|
| Leptin | 3 | 2021 | 1600 | 0.540 |
Why?
|
| Hospitalization | 7 | 2020 | 10259 | 0.540 |
Why?
|
| Avitaminosis | 3 | 2016 | 34 | 0.540 |
Why?
|
| International Cooperation | 2 | 2019 | 1420 | 0.540 |
Why?
|
| Risk | 10 | 2020 | 9688 | 0.530 |
Why?
|
| Molecular Epidemiology | 2 | 2016 | 468 | 0.530 |
Why?
|
| Plasmodium falciparum | 2 | 2020 | 1732 | 0.530 |
Why?
|
| Milk | 1 | 2018 | 450 | 0.520 |
Why?
|
| Commerce | 1 | 2021 | 592 | 0.520 |
Why?
|
| Anemia, Hypochromic | 2 | 2012 | 66 | 0.520 |
Why?
|
| Herpes Zoster | 1 | 2018 | 264 | 0.520 |
Why?
|
| Neural Tube Defects | 1 | 2017 | 256 | 0.510 |
Why?
|
| Depression | 10 | 2023 | 7759 | 0.510 |
Why?
|
| Maternal Age | 6 | 2016 | 802 | 0.510 |
Why?
|
| Calcium, Dietary | 2 | 2022 | 526 | 0.510 |
Why?
|
| Feeding Behavior | 6 | 2021 | 3188 | 0.510 |
Why?
|
| Interviews as Topic | 8 | 2021 | 2539 | 0.500 |
Why?
|
| Health Personnel | 4 | 2022 | 3219 | 0.500 |
Why?
|
| Family Planning Services | 2 | 2014 | 263 | 0.500 |
Why?
|
| Pregnancy Trimester, First | 5 | 2019 | 853 | 0.490 |
Why?
|
| Food Preferences | 1 | 2018 | 399 | 0.490 |
Why?
|
| Birth Intervals | 1 | 2014 | 51 | 0.490 |
Why?
|
| Diet Records | 6 | 2021 | 425 | 0.480 |
Why?
|
| Alanine Transaminase | 2 | 2019 | 592 | 0.480 |
Why?
|
| Clinical Protocols | 3 | 2017 | 1461 | 0.480 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2016 | 264 | 0.470 |
Why?
|
| Models, Economic | 1 | 2018 | 712 | 0.470 |
Why?
|
| Cost of Illness | 5 | 2016 | 1860 | 0.460 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2011 | 4386 | 0.450 |
Why?
|
| Plasma | 1 | 2016 | 575 | 0.450 |
Why?
|
| China | 9 | 2021 | 2245 | 0.450 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2009 | 500 | 0.450 |
Why?
|
| Syphilis | 2 | 2009 | 227 | 0.450 |
Why?
|
| Drug Resistance, Viral | 2 | 2016 | 820 | 0.440 |
Why?
|
| Measles Vaccine | 1 | 2013 | 76 | 0.440 |
Why?
|
| Hepatitis B | 3 | 2019 | 695 | 0.440 |
Why?
|
| Ecosystem | 1 | 2017 | 474 | 0.440 |
Why?
|
| Pandemics | 5 | 2023 | 8385 | 0.430 |
Why?
|
| Infant Food | 5 | 2019 | 141 | 0.430 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 985 | 0.420 |
Why?
|
| Nutrition Assessment | 7 | 2021 | 723 | 0.420 |
Why?
|
| Kaplan-Meier Estimate | 9 | 2020 | 6539 | 0.420 |
Why?
|
| Regression Analysis | 12 | 2016 | 6459 | 0.420 |
Why?
|
| Sanitation | 2 | 2021 | 93 | 0.410 |
Why?
|
| AIDS Serodiagnosis | 2 | 2004 | 184 | 0.410 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 2016 | 370 | 0.410 |
Why?
|
| Social Support | 4 | 2016 | 2118 | 0.410 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2013 | 187 | 0.410 |
Why?
|
| Mortality | 6 | 2020 | 2864 | 0.400 |
Why?
|
| Perinatal Care | 2 | 2014 | 227 | 0.400 |
Why?
|
| Diarrhea, Infantile | 2 | 2011 | 109 | 0.400 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2012 | 138 | 0.400 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2011 | 66 | 0.400 |
Why?
|
| Cause of Death | 7 | 2020 | 3582 | 0.400 |
Why?
|
| Night Blindness | 1 | 2011 | 53 | 0.400 |
Why?
|
| Mongolia | 4 | 2018 | 91 | 0.390 |
Why?
|
| Fertility | 2 | 2006 | 781 | 0.380 |
Why?
|
| Family Characteristics | 6 | 2020 | 1000 | 0.380 |
Why?
|
| Parity | 5 | 2014 | 929 | 0.380 |
Why?
|
| Plasmodium | 2 | 2012 | 250 | 0.380 |
Why?
|
| Inflammation | 8 | 2022 | 10637 | 0.380 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2022 | 56 | 0.380 |
Why?
|
| Continuity of Patient Care | 1 | 2018 | 1049 | 0.370 |
Why?
|
| Sputum | 4 | 2017 | 476 | 0.370 |
Why?
|
| Survival Analysis | 11 | 2019 | 10252 | 0.370 |
Why?
|
| Maternal Health Services | 4 | 2021 | 455 | 0.370 |
Why?
|
| Hemeproteins | 1 | 2010 | 62 | 0.360 |
Why?
|
| Fetal Macrosomia | 2 | 2022 | 124 | 0.360 |
Why?
|
| Lymphocyte Count | 7 | 2010 | 793 | 0.360 |
Why?
|
| Maternal Mortality | 4 | 2017 | 310 | 0.350 |
Why?
|
| Ambulatory Care Facilities | 3 | 2015 | 934 | 0.350 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 1405 | 0.350 |
Why?
|
| Cluster Analysis | 5 | 2020 | 2715 | 0.350 |
Why?
|
| Serum Albumin | 1 | 2013 | 675 | 0.350 |
Why?
|
| Puerperal Infection | 1 | 2009 | 46 | 0.350 |
Why?
|
| Telephone | 3 | 2021 | 617 | 0.350 |
Why?
|
| Water Supply | 2 | 2017 | 214 | 0.350 |
Why?
|
| Immunity | 2 | 2006 | 1014 | 0.340 |
Why?
|
| Antioxidants | 4 | 2005 | 1659 | 0.340 |
Why?
|
| Public Health | 2 | 2024 | 2602 | 0.340 |
Why?
|
| Anti-Bacterial Agents | 8 | 2013 | 7182 | 0.340 |
Why?
|
| Fetal Blood | 3 | 2021 | 1318 | 0.340 |
Why?
|
| Autopsy | 3 | 2020 | 1020 | 0.340 |
Why?
|
| Time Factors | 24 | 2019 | 40075 | 0.330 |
Why?
|
| Dyslipidemias | 3 | 2013 | 849 | 0.330 |
Why?
|
| Selenoproteins | 1 | 2010 | 216 | 0.330 |
Why?
|
| Pica | 1 | 2009 | 32 | 0.330 |
Why?
|
| Safe Sex | 1 | 2009 | 141 | 0.330 |
Why?
|
| Biomedical Research | 4 | 2019 | 3309 | 0.330 |
Why?
|
| Logistic Models | 14 | 2021 | 13409 | 0.320 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2008 | 1837 | 0.320 |
Why?
|
| Comorbidity | 9 | 2016 | 10388 | 0.320 |
Why?
|
| Helminthiasis | 1 | 2009 | 66 | 0.320 |
Why?
|
| Soil | 1 | 2009 | 106 | 0.320 |
Why?
|
| Quality of Life | 8 | 2019 | 12802 | 0.320 |
Why?
|
| Carotenoids | 3 | 2012 | 624 | 0.320 |
Why?
|
| Sex Education | 1 | 2008 | 93 | 0.320 |
Why?
|
| Disease Transmission, Infectious | 1 | 2014 | 547 | 0.320 |
Why?
|
| Pregnancy in Adolescence | 2 | 2019 | 158 | 0.310 |
Why?
|
| Confidence Intervals | 8 | 2012 | 2971 | 0.310 |
Why?
|
| Anemia, Sickle Cell | 1 | 2016 | 1020 | 0.310 |
Why?
|
| Statistics as Topic | 5 | 2018 | 2373 | 0.300 |
Why?
|
| Child Welfare | 1 | 2012 | 523 | 0.300 |
Why?
|
| Community Health Services | 4 | 2019 | 650 | 0.300 |
Why?
|
| Isoniazid | 3 | 2018 | 274 | 0.300 |
Why?
|
| Genital Diseases, Female | 1 | 2008 | 197 | 0.300 |
Why?
|
| C-Reactive Protein | 7 | 2022 | 3778 | 0.300 |
Why?
|
| Condoms | 1 | 2009 | 323 | 0.290 |
Why?
|
| Africa | 6 | 2021 | 672 | 0.290 |
Why?
|
| Infection Control | 2 | 2012 | 965 | 0.290 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 1351 | 0.290 |
Why?
|
| Chorioamnionitis | 5 | 2009 | 155 | 0.290 |
Why?
|
| Eating | 3 | 2022 | 1536 | 0.280 |
Why?
|
| DNA, Viral | 4 | 2012 | 2227 | 0.280 |
Why?
|
| Intelligence | 3 | 2021 | 920 | 0.280 |
Why?
|
| Severity of Illness Index | 8 | 2018 | 15535 | 0.270 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2017 | 1832 | 0.270 |
Why?
|
| Telemedicine | 1 | 2023 | 2872 | 0.270 |
Why?
|
| Flagellin | 2 | 2017 | 125 | 0.270 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2019 | 623 | 0.270 |
Why?
|
| Health Surveys | 8 | 2020 | 4036 | 0.270 |
Why?
|
| Hypertension | 6 | 2017 | 8479 | 0.270 |
Why?
|
| Skin Diseases | 1 | 2014 | 1066 | 0.270 |
Why?
|
| Community-Acquired Infections | 3 | 2005 | 465 | 0.260 |
Why?
|
| Immunoglobulin A | 3 | 2023 | 995 | 0.260 |
Why?
|
| Health Services Accessibility | 6 | 2022 | 5135 | 0.260 |
Why?
|
| Food | 3 | 2023 | 772 | 0.260 |
Why?
|
| Seasons | 7 | 2018 | 1493 | 0.260 |
Why?
|
| Zambia | 4 | 2009 | 261 | 0.250 |
Why?
|
| Sleep Deprivation | 1 | 2012 | 832 | 0.250 |
Why?
|
| Hyperglycemia | 1 | 2014 | 1373 | 0.250 |
Why?
|
| Case-Control Studies | 11 | 2022 | 21748 | 0.250 |
Why?
|
| Malawi | 4 | 2009 | 282 | 0.250 |
Why?
|
| Poisson Distribution | 2 | 2017 | 513 | 0.250 |
Why?
|
| Gonorrhea | 1 | 2009 | 335 | 0.250 |
Why?
|
| Review Literature as Topic | 2 | 2024 | 336 | 0.240 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2009 | 639 | 0.240 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2005 | 226 | 0.240 |
Why?
|
| Odds Ratio | 10 | 2016 | 9849 | 0.240 |
Why?
|
| Health Status Disparities | 1 | 2016 | 1796 | 0.240 |
Why?
|
| Administration, Oral | 5 | 2017 | 3914 | 0.230 |
Why?
|
| Asia | 5 | 2017 | 609 | 0.230 |
Why?
|
| Hygiene | 2 | 2019 | 97 | 0.230 |
Why?
|
| Communication | 2 | 2015 | 3750 | 0.230 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 4925 | 0.230 |
Why?
|
| Bangladesh | 4 | 2021 | 687 | 0.230 |
Why?
|
| Language Development | 3 | 2019 | 187 | 0.220 |
Why?
|
| Cough | 4 | 2019 | 555 | 0.220 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2018 | 1344 | 0.220 |
Why?
|
| Body Weights and Measures | 2 | 2019 | 211 | 0.210 |
Why?
|
| Lipids | 2 | 2013 | 3307 | 0.210 |
Why?
|
| Environmental Exposure | 1 | 2017 | 4232 | 0.210 |
Why?
|
| Drug Administration Schedule | 5 | 2017 | 4933 | 0.210 |
Why?
|
| Fetal Death | 4 | 2007 | 448 | 0.210 |
Why?
|
| Vagina | 2 | 2007 | 825 | 0.210 |
Why?
|
| Smoking | 3 | 2017 | 8987 | 0.200 |
Why?
|
| Overnutrition | 1 | 2021 | 26 | 0.200 |
Why?
|
| Antibodies, Viral | 1 | 2013 | 3177 | 0.200 |
Why?
|
| Meta-Analysis as Topic | 2 | 2020 | 1342 | 0.200 |
Why?
|
| Postnatal Care | 2 | 2014 | 236 | 0.200 |
Why?
|
| Risk Assessment | 13 | 2019 | 23336 | 0.200 |
Why?
|
| School Health Services | 2 | 2022 | 375 | 0.200 |
Why?
|
| Executive Function | 2 | 2021 | 1364 | 0.190 |
Why?
|
| Nepal | 6 | 2019 | 295 | 0.190 |
Why?
|
| Child Nutrition Sciences | 1 | 2020 | 23 | 0.190 |
Why?
|
| Interleukin-1beta | 1 | 2006 | 972 | 0.190 |
Why?
|
| Body Composition | 2 | 2011 | 2402 | 0.190 |
Why?
|
| Communicable Disease Control | 2 | 2023 | 856 | 0.190 |
Why?
|
| Health Promotion | 4 | 2021 | 2205 | 0.180 |
Why?
|
| Cooking | 3 | 2017 | 313 | 0.180 |
Why?
|
| Men | 1 | 2020 | 63 | 0.180 |
Why?
|
| Flow Cytometry | 2 | 2011 | 5974 | 0.180 |
Why?
|
| Length of Stay | 1 | 2013 | 6311 | 0.180 |
Why?
|
| Middle East | 1 | 2020 | 219 | 0.180 |
Why?
|
| Student Dropouts | 1 | 2019 | 27 | 0.180 |
Why?
|
| Interleukin-1 | 1 | 2004 | 1263 | 0.180 |
Why?
|
| Rural Health | 2 | 2019 | 305 | 0.180 |
Why?
|
| Medication Adherence | 3 | 2018 | 2063 | 0.170 |
Why?
|
| Calcium Compounds | 1 | 2019 | 34 | 0.170 |
Why?
|
| Alcohol Drinking | 5 | 2019 | 3966 | 0.170 |
Why?
|
| MEDLINE | 1 | 2019 | 125 | 0.170 |
Why?
|
| Age Distribution | 2 | 2016 | 2902 | 0.170 |
Why?
|
| Citrulline | 1 | 2019 | 105 | 0.170 |
Why?
|
| BCG Vaccine | 1 | 2022 | 369 | 0.170 |
Why?
|
| Mastitis | 2 | 2010 | 41 | 0.170 |
Why?
|
| Maternal Exposure | 2 | 2016 | 961 | 0.170 |
Why?
|
| Maternal Behavior | 1 | 2021 | 311 | 0.170 |
Why?
|
| Life Style | 5 | 2022 | 3835 | 0.170 |
Why?
|
| Intention to Treat Analysis | 1 | 2020 | 426 | 0.170 |
Why?
|
| Caregivers | 3 | 2022 | 2095 | 0.170 |
Why?
|
| Air Pollution, Indoor | 2 | 2016 | 857 | 0.170 |
Why?
|
| Lipopolysaccharides | 2 | 2017 | 2216 | 0.160 |
Why?
|
| Analysis of Variance | 4 | 2013 | 6366 | 0.160 |
Why?
|
| Gastrointestinal Diseases | 2 | 2018 | 1170 | 0.160 |
Why?
|
| Food Services | 1 | 2021 | 192 | 0.160 |
Why?
|
| Intelligence Tests | 1 | 2019 | 505 | 0.160 |
Why?
|
| Public Policy | 1 | 2023 | 572 | 0.160 |
Why?
|
| Antimalarials | 4 | 2012 | 905 | 0.160 |
Why?
|
| Education, Nonprofessional | 1 | 2018 | 34 | 0.160 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2009 | 582 | 0.160 |
Why?
|
| Nutritional Requirements | 1 | 2020 | 286 | 0.160 |
Why?
|
| Education | 2 | 2016 | 543 | 0.160 |
Why?
|
| Pregnancy Trimesters | 1 | 2019 | 192 | 0.160 |
Why?
|
| Reproducibility of Results | 7 | 2019 | 19905 | 0.160 |
Why?
|
| HIV Long Terminal Repeat | 4 | 2006 | 88 | 0.160 |
Why?
|
| Knowledge | 1 | 2019 | 181 | 0.160 |
Why?
|
| Blood Pressure | 5 | 2017 | 8551 | 0.160 |
Why?
|
| Beverages | 2 | 2021 | 821 | 0.160 |
Why?
|
| Mother-Child Relations | 1 | 2021 | 481 | 0.150 |
Why?
|
| Latin America | 2 | 2016 | 380 | 0.150 |
Why?
|
| Receptors, Transferrin | 2 | 2016 | 296 | 0.150 |
Why?
|
| Punishment | 1 | 2018 | 98 | 0.150 |
Why?
|
| Livestock | 1 | 2017 | 19 | 0.150 |
Why?
|
| Medication Therapy Management | 1 | 2018 | 127 | 0.150 |
Why?
|
| Oxides | 1 | 2019 | 405 | 0.150 |
Why?
|
| Aged | 21 | 2021 | 163288 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2019 | 3020 | 0.150 |
Why?
|
| Fruit | 2 | 2020 | 1142 | 0.150 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 1677 | 0.150 |
Why?
|
| Health Services | 1 | 2022 | 758 | 0.150 |
Why?
|
| Vegetables | 2 | 2020 | 1182 | 0.150 |
Why?
|
| Xerophthalmia | 2 | 1993 | 18 | 0.150 |
Why?
|
| Program Evaluation | 3 | 2023 | 2488 | 0.150 |
Why?
|
| Animals, Wild | 1 | 2017 | 90 | 0.150 |
Why?
|
| Predictive Value of Tests | 7 | 2009 | 15078 | 0.150 |
Why?
|
| Confidentiality | 1 | 2001 | 612 | 0.150 |
Why?
|
| Nervous System | 2 | 2014 | 554 | 0.150 |
Why?
|
| Botswana | 5 | 2022 | 1040 | 0.140 |
Why?
|
| Intestinal Diseases | 2 | 2019 | 530 | 0.140 |
Why?
|
| Apgar Score | 1 | 2016 | 123 | 0.140 |
Why?
|
| Recombination, Genetic | 6 | 2006 | 1586 | 0.140 |
Why?
|
| Violence | 2 | 2019 | 909 | 0.140 |
Why?
|
| Dairy Products | 1 | 2020 | 498 | 0.140 |
Why?
|
| Acute Disease | 2 | 2020 | 7147 | 0.140 |
Why?
|
| Databases, Factual | 3 | 2018 | 7730 | 0.140 |
Why?
|
| Prediabetic State | 1 | 2021 | 499 | 0.140 |
Why?
|
| Zoonoses | 1 | 2017 | 185 | 0.140 |
Why?
|
| Carbon Monoxide | 2 | 2016 | 531 | 0.140 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2016 | 361 | 0.140 |
Why?
|
| Residence Characteristics | 4 | 2019 | 2050 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 3 | 2017 | 6171 | 0.130 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2019 | 546 | 0.130 |
Why?
|
| Protoporphyrins | 1 | 2016 | 164 | 0.130 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 10183 | 0.130 |
Why?
|
| Immunoglobulin G | 3 | 2023 | 4561 | 0.130 |
Why?
|
| Immunocompromised Host | 2 | 2017 | 847 | 0.130 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2015 | 387 | 0.130 |
Why?
|
| Child, Orphaned | 1 | 2016 | 55 | 0.130 |
Why?
|
| Translating | 1 | 2016 | 144 | 0.130 |
Why?
|
| Animals | 10 | 2022 | 168768 | 0.130 |
Why?
|
| Communication Disorders | 1 | 2015 | 51 | 0.130 |
Why?
|
| Motor Skills Disorders | 1 | 2015 | 90 | 0.130 |
Why?
|
| Nurses | 2 | 2022 | 2462 | 0.130 |
Why?
|
| Physical Education and Training | 1 | 2015 | 106 | 0.130 |
Why?
|
| Lost to Follow-Up | 1 | 2015 | 105 | 0.130 |
Why?
|
| Community Health Planning | 1 | 2016 | 165 | 0.130 |
Why?
|
| Parturition | 3 | 2014 | 441 | 0.130 |
Why?
|
| Risk-Taking | 2 | 2019 | 986 | 0.130 |
Why?
|
| Blood Cell Count | 1 | 2016 | 403 | 0.130 |
Why?
|
| Health Education | 2 | 2024 | 1056 | 0.130 |
Why?
|
| Egypt | 2 | 2011 | 100 | 0.130 |
Why?
|
| Maternal-Child Health Centers | 1 | 2014 | 40 | 0.130 |
Why?
|
| Health Systems Plans | 1 | 2014 | 18 | 0.130 |
Why?
|
| Women's Health | 3 | 2014 | 2034 | 0.120 |
Why?
|
| Measles | 2 | 1995 | 168 | 0.120 |
Why?
|
| Spouse Abuse | 1 | 2016 | 178 | 0.120 |
Why?
|
| Anxiety | 3 | 2017 | 4293 | 0.120 |
Why?
|
| Pregnancy, Multiple | 1 | 2015 | 217 | 0.120 |
Why?
|
| Alkynes | 1 | 2015 | 306 | 0.120 |
Why?
|
| Zinc Sulfate | 1 | 2013 | 17 | 0.120 |
Why?
|
| Health | 1 | 2017 | 394 | 0.120 |
Why?
|
| Tuberculin | 1 | 2013 | 66 | 0.120 |
Why?
|
| Angiopoietins | 1 | 2014 | 80 | 0.120 |
Why?
|
| Birth Order | 1 | 2014 | 95 | 0.120 |
Why?
|
| Phytohemagglutinins | 1 | 2013 | 170 | 0.120 |
Why?
|
| Endemic Diseases | 1 | 2014 | 182 | 0.120 |
Why?
|
| Europe | 1 | 2020 | 3338 | 0.120 |
Why?
|
| Reproductive Health Services | 1 | 2014 | 80 | 0.120 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2015 | 1159 | 0.120 |
Why?
|
| Drug Therapy, Combination | 5 | 2017 | 6489 | 0.120 |
Why?
|
| Cyclopropanes | 1 | 2015 | 416 | 0.110 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2016 | 456 | 0.110 |
Why?
|
| Benzoxazines | 1 | 2015 | 301 | 0.110 |
Why?
|
| Hepatitis B, Chronic | 1 | 2017 | 393 | 0.110 |
Why?
|
| Pregnancy Proteins | 1 | 2014 | 229 | 0.110 |
Why?
|
| Placenta Diseases | 1 | 2015 | 199 | 0.110 |
Why?
|
| Zidovudine | 1 | 2015 | 620 | 0.110 |
Why?
|
| Fever | 3 | 2012 | 1616 | 0.110 |
Why?
|
| Evidence-Based Medicine | 2 | 2017 | 3611 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2019 | 1240 | 0.110 |
Why?
|
| Triage | 1 | 2019 | 977 | 0.110 |
Why?
|
| Antibody Affinity | 1 | 2013 | 254 | 0.110 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 875 | 0.110 |
Why?
|
| Erythrocyte Indices | 1 | 2013 | 146 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2019 | 10943 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2022 | 1184 | 0.100 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 722 | 0.100 |
Why?
|
| Home Care Services | 1 | 2018 | 606 | 0.100 |
Why?
|
| Psychomotor Disorders | 1 | 2012 | 152 | 0.100 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2014 | 357 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2002 | 6036 | 0.100 |
Why?
|
| Candidiasis, Oral | 1 | 2011 | 60 | 0.100 |
Why?
|
| Goals | 1 | 2017 | 707 | 0.100 |
Why?
|
| Child Health Services | 2 | 2021 | 667 | 0.100 |
Why?
|
| Emotions | 3 | 2021 | 2659 | 0.100 |
Why?
|
| Students | 1 | 2021 | 1647 | 0.100 |
Why?
|
| Sexual Partners | 2 | 2009 | 729 | 0.100 |
Why?
|
| Chemoprevention | 1 | 2014 | 319 | 0.100 |
Why?
|
| Tuberculin Test | 1 | 2012 | 214 | 0.100 |
Why?
|
| Organ Size | 1 | 2016 | 2251 | 0.100 |
Why?
|
| Microchip Analytical Procedures | 1 | 2011 | 29 | 0.100 |
Why?
|
| Area Under Curve | 2 | 2019 | 1655 | 0.100 |
Why?
|
| Delivery, Obstetric | 1 | 2018 | 906 | 0.100 |
Why?
|
| Obstetric Labor, Premature | 2 | 2004 | 279 | 0.100 |
Why?
|
| Poverty Areas | 1 | 2012 | 275 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2014 | 552 | 0.100 |
Why?
|
| Algorithms | 3 | 2021 | 13882 | 0.100 |
Why?
|
| Dietary Fats | 2 | 2021 | 2016 | 0.100 |
Why?
|
| Urbanization | 1 | 2011 | 104 | 0.100 |
Why?
|
| Complement System Proteins | 1 | 2014 | 795 | 0.100 |
Why?
|
| Vaccination | 2 | 2022 | 3279 | 0.090 |
Why?
|
| Intestines | 2 | 2017 | 1924 | 0.090 |
Why?
|
| Vitamin E Deficiency | 1 | 2010 | 32 | 0.090 |
Why?
|
| Brazil | 3 | 2019 | 1270 | 0.090 |
Why?
|
| Hematologic Diseases | 1 | 2014 | 498 | 0.090 |
Why?
|
| Patient Admission | 1 | 2018 | 1380 | 0.090 |
Why?
|
| Cholesterol | 2 | 2017 | 2919 | 0.090 |
Why?
|
| Iron Overload | 1 | 2012 | 242 | 0.090 |
Why?
|
| Bottle Feeding | 1 | 2010 | 66 | 0.090 |
Why?
|
| Cell-Free System | 2 | 2007 | 344 | 0.090 |
Why?
|
| Body Size | 1 | 2013 | 461 | 0.090 |
Why?
|
| Exercise | 4 | 2019 | 5615 | 0.090 |
Why?
|
| Blood Sedimentation | 1 | 2010 | 231 | 0.090 |
Why?
|
| Social Behavior | 1 | 2016 | 1127 | 0.090 |
Why?
|
| Haplotypes | 1 | 2016 | 2779 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2021 | 1479 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 1888 | 0.090 |
Why?
|
| Models, Statistical | 2 | 2021 | 5101 | 0.090 |
Why?
|
| Vomiting | 1 | 2012 | 637 | 0.090 |
Why?
|
| Ascariasis | 1 | 2009 | 12 | 0.090 |
Why?
|
| Latent Tuberculosis | 1 | 2012 | 225 | 0.090 |
Why?
|
| Ascaris lumbricoides | 1 | 2009 | 11 | 0.090 |
Why?
|
| Parent-Child Relations | 2 | 2017 | 747 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 1572 | 0.080 |
Why?
|
| Syphilis, Congenital | 1 | 2009 | 24 | 0.080 |
Why?
|
| Visual Acuity | 1 | 2018 | 2530 | 0.080 |
Why?
|
| Dietary Carbohydrates | 1 | 2014 | 905 | 0.080 |
Why?
|
| Endpoint Determination | 1 | 2011 | 601 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 14723 | 0.080 |
Why?
|
| Lauric Acids | 1 | 2007 | 9 | 0.080 |
Why?
|
| Receptors, Cell Surface | 2 | 2015 | 2865 | 0.080 |
Why?
|
| Fatty Acids | 2 | 2007 | 1809 | 0.080 |
Why?
|
| gamma-Linolenic Acid | 1 | 2007 | 16 | 0.080 |
Why?
|
| Particulate Matter | 2 | 2016 | 2529 | 0.080 |
Why?
|
| Health Resources | 2 | 2019 | 911 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5388 | 0.080 |
Why?
|
| Peer Group | 1 | 2012 | 635 | 0.080 |
Why?
|
| Patients | 1 | 2014 | 900 | 0.080 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 1862 | 0.070 |
Why?
|
| Causality | 1 | 2014 | 1275 | 0.070 |
Why?
|
| Software | 1 | 2021 | 4441 | 0.070 |
Why?
|
| Obstetric Labor Complications | 1 | 2009 | 238 | 0.070 |
Why?
|
| Job Satisfaction | 1 | 2011 | 534 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2015 | 2020 | 0.070 |
Why?
|
| Ghana | 2 | 2022 | 284 | 0.070 |
Why?
|
| Arachidonic Acids | 1 | 2007 | 299 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2015 | 4026 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1157 | 0.070 |
Why?
|
| Fetal Proteins | 1 | 2007 | 94 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2018 | 2708 | 0.070 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2011 | 428 | 0.070 |
Why?
|
| Environment | 3 | 2018 | 1123 | 0.070 |
Why?
|
| Physician's Role | 1 | 2014 | 943 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 941 | 0.070 |
Why?
|
| Blood | 1 | 2009 | 598 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2017 | 2616 | 0.070 |
Why?
|
| Blood Glucose | 3 | 2021 | 6254 | 0.070 |
Why?
|
| Developed Countries | 1 | 2009 | 437 | 0.070 |
Why?
|
| Prognosis | 4 | 2013 | 29060 | 0.070 |
Why?
|
| Cell Count | 1 | 2010 | 1856 | 0.070 |
Why?
|
| Health Status Indicators | 1 | 2011 | 970 | 0.070 |
Why?
|
| Karnofsky Performance Status | 1 | 2006 | 173 | 0.070 |
Why?
|
| Erythropoietin | 1 | 2010 | 726 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 57776 | 0.070 |
Why?
|
| Chloroquine | 2 | 2005 | 279 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2019 | 77460 | 0.060 |
Why?
|
| Term Birth | 2 | 2016 | 135 | 0.060 |
Why?
|
| Sex Characteristics | 2 | 2011 | 2585 | 0.060 |
Why?
|
| CD4-CD8 Ratio | 1 | 2005 | 112 | 0.060 |
Why?
|
| gamma-Tocopherol | 1 | 2004 | 31 | 0.060 |
Why?
|
| alpha-Linolenic Acid | 1 | 2005 | 144 | 0.060 |
Why?
|
| Lung Diseases | 1 | 1995 | 1887 | 0.060 |
Why?
|
| Linoleic Acid | 1 | 2005 | 157 | 0.060 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5321 | 0.060 |
Why?
|
| Lutein | 1 | 2004 | 125 | 0.060 |
Why?
|
| Specimen Handling | 1 | 2009 | 694 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 1901 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 1831 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3589 | 0.060 |
Why?
|
| Sample Size | 2 | 2015 | 845 | 0.060 |
Why?
|
| Neutrophil Infiltration | 1 | 2006 | 391 | 0.060 |
Why?
|
| Drug Combinations | 2 | 2014 | 1958 | 0.060 |
Why?
|
| Reference Values | 3 | 2017 | 4982 | 0.060 |
Why?
|
| Point-of-Care Systems | 3 | 2019 | 1178 | 0.060 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2007 | 582 | 0.060 |
Why?
|
| South America | 2 | 2013 | 181 | 0.060 |
Why?
|
| Fibronectins | 1 | 2007 | 726 | 0.060 |
Why?
|
| Quality Improvement | 2 | 2017 | 3749 | 0.060 |
Why?
|
| Genes, env | 2 | 2004 | 95 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3511 | 0.060 |
Why?
|
| Thailand | 1 | 2023 | 296 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3873 | 0.050 |
Why?
|
| Air Pollution | 1 | 2016 | 2286 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2022 | 2016 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 5524 | 0.050 |
Why?
|
| Fishes | 1 | 2005 | 569 | 0.050 |
Why?
|
| Respiration Disorders | 1 | 2005 | 371 | 0.050 |
Why?
|
| Parents | 1 | 2016 | 3405 | 0.050 |
Why?
|
| Herpes Genitalis | 1 | 2003 | 140 | 0.050 |
Why?
|
| Electric Impedance | 1 | 2006 | 729 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 4479 | 0.050 |
Why?
|
| Abortion, Spontaneous | 1 | 2007 | 544 | 0.050 |
Why?
|
| Cardiovascular Diseases | 4 | 2011 | 15160 | 0.050 |
Why?
|
| United States | 7 | 2023 | 69872 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2014 | 3531 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2003 | 189 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2008 | 1530 | 0.050 |
Why?
|
| Parasitic Diseases | 1 | 2001 | 75 | 0.050 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2008 | 1203 | 0.050 |
Why?
|
| Disease Notification | 1 | 2001 | 97 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2015 | 4043 | 0.050 |
Why?
|
| Motivation | 1 | 2011 | 1971 | 0.050 |
Why?
|
| Gene Products, env | 4 | 2006 | 263 | 0.050 |
Why?
|
| Teaching | 1 | 2008 | 1174 | 0.050 |
Why?
|
| Cultural Characteristics | 1 | 2002 | 262 | 0.050 |
Why?
|
| Disease Outbreaks | 2 | 2002 | 1771 | 0.050 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2022 | 300 | 0.050 |
Why?
|
| Immunocompetence | 1 | 2000 | 136 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2005 | 3508 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2010 | 2455 | 0.050 |
Why?
|
| Psychometrics | 2 | 2017 | 3003 | 0.050 |
Why?
|
| Recurrence | 1 | 2012 | 8340 | 0.050 |
Why?
|
| Data Collection | 2 | 2021 | 3339 | 0.040 |
Why?
|
| Carbohydrates | 1 | 2022 | 394 | 0.040 |
Why?
|
| Social Environment | 2 | 2018 | 1022 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2022 | 705 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2022 | 364 | 0.040 |
Why?
|
| Leukocytes | 1 | 2007 | 2045 | 0.040 |
Why?
|
| Mexico | 1 | 2021 | 689 | 0.040 |
Why?
|
| Body Temperature | 2 | 2003 | 777 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 1837 | 0.040 |
Why?
|
| Cytokines | 1 | 2014 | 7323 | 0.040 |
Why?
|
| Survival Rate | 1 | 2013 | 12788 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2001 | 273 | 0.040 |
Why?
|
| Government Programs | 1 | 2021 | 275 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2017 | 6994 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2022 | 881 | 0.040 |
Why?
|
| Orosomucoid | 1 | 2018 | 45 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2004 | 2297 | 0.040 |
Why?
|
| Spouses | 1 | 2021 | 286 | 0.040 |
Why?
|
| Biological Availability | 1 | 2019 | 397 | 0.040 |
Why?
|
| Calcifediol | 1 | 2019 | 166 | 0.040 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1998 | 159 | 0.040 |
Why?
|
| Health Services Research | 2 | 2017 | 1836 | 0.040 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2007 | 1008 | 0.040 |
Why?
|
| Survivors | 1 | 2008 | 2291 | 0.040 |
Why?
|
| Sunlight | 1 | 2019 | 325 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2013 | 19233 | 0.040 |
Why?
|
| Molecular Sequence Data | 7 | 2006 | 18111 | 0.040 |
Why?
|
| Capsid Proteins | 1 | 2001 | 479 | 0.040 |
Why?
|
| Africa, Northern | 1 | 1997 | 82 | 0.040 |
Why?
|
| Sensation | 1 | 2019 | 336 | 0.040 |
Why?
|
| Skin Pigmentation | 1 | 2019 | 282 | 0.040 |
Why?
|
| Herpesvirus 1, Human | 1 | 2003 | 743 | 0.040 |
Why?
|
| Skinfold Thickness | 1 | 1997 | 162 | 0.040 |
Why?
|
| Methylmalonic Acid | 1 | 2017 | 49 | 0.040 |
Why?
|
| Campylobacter | 1 | 2017 | 59 | 0.040 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2017 | 27 | 0.040 |
Why?
|
| Interleukins | 1 | 2021 | 791 | 0.040 |
Why?
|
| Uterus | 1 | 2001 | 711 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 3841 | 0.040 |
Why?
|
| Food Analysis | 1 | 2017 | 104 | 0.040 |
Why?
|
| Workplace | 1 | 2003 | 836 | 0.040 |
Why?
|
| Cryptosporidium | 1 | 2017 | 45 | 0.040 |
Why?
|
| Peru | 1 | 2019 | 881 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 424 | 0.030 |
Why?
|
| Shigella | 1 | 2017 | 74 | 0.030 |
Why?
|
| Psychological Techniques | 1 | 2016 | 45 | 0.030 |
Why?
|
| Aspartate Aminotransferases | 1 | 2017 | 418 | 0.030 |
Why?
|
| Rotavirus | 1 | 2017 | 109 | 0.030 |
Why?
|
| Sleep | 1 | 2012 | 4622 | 0.030 |
Why?
|
| Philippines | 1 | 2015 | 86 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2011 | 4245 | 0.030 |
Why?
|
| Child Behavior | 1 | 2021 | 839 | 0.030 |
Why?
|
| Economics | 1 | 2016 | 146 | 0.030 |
Why?
|
| Fasting | 1 | 2021 | 1592 | 0.030 |
Why?
|
| Contraception Behavior | 1 | 2017 | 185 | 0.030 |
Why?
|
| Mental Recall | 1 | 2021 | 1206 | 0.030 |
Why?
|
| Adolescent Nutritional Physiological Phenomena | 1 | 2015 | 63 | 0.030 |
Why?
|
| Seeds | 1 | 2015 | 105 | 0.030 |
Why?
|
| Platelet Count | 1 | 2017 | 780 | 0.030 |
Why?
|
| Potassium | 2 | 2010 | 1336 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1999 | 952 | 0.030 |
Why?
|
| Smoke | 1 | 2016 | 227 | 0.030 |
Why?
|
| Israel | 1 | 1997 | 796 | 0.030 |
Why?
|
| Capsules | 1 | 2014 | 196 | 0.030 |
Why?
|
| Disabled Children | 1 | 2017 | 247 | 0.030 |
Why?
|
| Finland | 1 | 2015 | 602 | 0.030 |
Why?
|
| Psychology | 1 | 2016 | 356 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2005 | 3084 | 0.030 |
Why?
|
| Diterpenes | 1 | 2014 | 173 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2007 | 3747 | 0.030 |
Why?
|
| Homocysteine | 1 | 2017 | 647 | 0.030 |
Why?
|
| Zimbabwe | 1 | 2013 | 129 | 0.030 |
Why?
|
| Sodium | 2 | 2010 | 1622 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 633 | 0.030 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 1470 | 0.030 |
Why?
|
| Counseling | 1 | 2001 | 1523 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 1999 | 792 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2001 | 1900 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2017 | 651 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 11726 | 0.030 |
Why?
|
| House Calls | 1 | 2014 | 160 | 0.030 |
Why?
|
| Adipokines | 1 | 2015 | 320 | 0.030 |
Why?
|
| Lectins | 1 | 2015 | 513 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 1998 | 1000 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2012 | 6598 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2014 | 1681 | 0.030 |
Why?
|
| Vaginal Smears | 1 | 2015 | 511 | 0.030 |
Why?
|
| Genotype | 5 | 2009 | 12952 | 0.030 |
Why?
|
| Benchmarking | 1 | 2018 | 1042 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 1999 | 1322 | 0.030 |
Why?
|
| Learning | 1 | 2021 | 1711 | 0.030 |
Why?
|
| Stavudine | 1 | 2011 | 85 | 0.020 |
Why?
|
| Respiration | 1 | 1998 | 1653 | 0.020 |
Why?
|
| Mass Screening | 2 | 2021 | 5253 | 0.020 |
Why?
|
| Feces | 1 | 2017 | 1401 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2014 | 417 | 0.020 |
Why?
|
| Family | 1 | 2001 | 3147 | 0.020 |
Why?
|
| HIV Core Protein p24 | 2 | 2001 | 256 | 0.020 |
Why?
|
| Consensus Sequence | 2 | 2001 | 378 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2017 | 1035 | 0.020 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2009 | 54 | 0.020 |
Why?
|
| Gene Products, gag | 2 | 2001 | 337 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3954 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2015 | 1877 | 0.020 |
Why?
|
| Desiccation | 1 | 2009 | 71 | 0.020 |
Why?
|
| Drug Antagonism | 1 | 2008 | 50 | 0.020 |
Why?
|
| South Africa | 1 | 2013 | 1731 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2008 | 6773 | 0.020 |
Why?
|
| Dwarfism | 1 | 2009 | 146 | 0.020 |
Why?
|
| Aging | 2 | 1997 | 8664 | 0.020 |
Why?
|
| Calcium Carbonate | 1 | 2008 | 67 | 0.020 |
Why?
|
| Internationality | 1 | 2014 | 1002 | 0.020 |
Why?
|
| Tocopherols | 1 | 2007 | 43 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 640 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1677 | 0.020 |
Why?
|
| Genetic Variation | 2 | 2000 | 6542 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2011 | 917 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2015 | 2307 | 0.020 |
Why?
|
| International Educational Exchange | 1 | 2007 | 50 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 638 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1999 | 5096 | 0.020 |
Why?
|
| Oxygen | 1 | 1998 | 4189 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 1410 | 0.020 |
Why?
|
| Erythromycin | 1 | 2006 | 120 | 0.020 |
Why?
|
| HIV Seroprevalence | 1 | 2006 | 86 | 0.020 |
Why?
|
| Marital Status | 1 | 2007 | 437 | 0.020 |
Why?
|
| Metronidazole | 1 | 2006 | 217 | 0.020 |
Why?
|
| Neoplasms | 2 | 2011 | 21696 | 0.020 |
Why?
|
| Forecasting | 1 | 2014 | 2951 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2018 | 3208 | 0.020 |
Why?
|
| Workload | 1 | 2011 | 849 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 2278 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2016 | 2494 | 0.010 |
Why?
|
| Base Sequence | 3 | 2001 | 12797 | 0.010 |
Why?
|
| Phylogeny | 2 | 2001 | 2804 | 0.010 |
Why?
|
| Triglycerides | 1 | 2011 | 2453 | 0.010 |
Why?
|
| Temperature | 1 | 2009 | 2204 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5077 | 0.010 |
Why?
|
| Air Pollutants | 1 | 2016 | 2816 | 0.010 |
Why?
|
| Health Policy | 1 | 2014 | 2661 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2017 | 4369 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2009 | 1167 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 2006 | 4805 | 0.010 |
Why?
|
| Species Specificity | 1 | 2006 | 2478 | 0.010 |
Why?
|
| Leisure Activities | 1 | 2002 | 311 | 0.010 |
Why?
|
| Employment | 1 | 2007 | 1132 | 0.010 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 222 | 0.010 |
Why?
|
| Postmenopause | 1 | 2008 | 2460 | 0.010 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 1998 | 65 | 0.010 |
Why?
|
| Capsid | 1 | 2001 | 437 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 15520 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2003 | 1608 | 0.010 |
Why?
|
| Genome, Viral | 1 | 2001 | 667 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2011 | 9145 | 0.010 |
Why?
|
| Travel | 1 | 2002 | 788 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2006 | 6896 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2000 | 914 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1999 | 2256 | 0.010 |
Why?
|
| Iraq | 1 | 1994 | 92 | 0.010 |
Why?
|
| Fetus | 1 | 2001 | 1880 | 0.010 |
Why?
|
| Students, Medical | 1 | 2007 | 1862 | 0.010 |
Why?
|
| Curriculum | 1 | 2007 | 3605 | 0.010 |
Why?
|
| Alcoholism | 1 | 2003 | 1906 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 5749 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2007 | 4687 | 0.010 |
Why?
|
| Genome | 1 | 1999 | 1807 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1999 | 13814 | 0.000 |
Why?
|
| Mutation | 1 | 2000 | 29786 | 0.000 |
Why?
|